Protagonist Therapeutics
PTGX· Manufacturing· Fiscal year ends in December
Dinesh V. Patel, Ph.D. is the CEO of Protagonist Therapeutics and was paid $12.9M in FY2025 (Dec), up 36%.
Executives3
See all- 1Dinesh V. Patel, Ph.D.President and Chief Executive OfficerFY2025
- 2Arturo Molina, M.D., M.S., F.A.C.P.Chief Medical OfficerFY2025
- 3Asif AliEVP, Chief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allProtagonist Therapeutics paid its 3 named executives $20.2M in total in FY2025 (Dec). CEO Dinesh V. Patel, Ph.D. was paid $12.9M of that.
| Name | |||
|---|---|---|---|
| Dinesh V. Patel, Ph.D.President and Chief Executive Officer | |||
| Arturo Molina, M.D., M.S., F.A.C.P.Chief Medical Officer | Not disclosed | ||
| Asif AliEVP, Chief Financial Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers19
See allThe FY2025 (Dec) proxy of Protagonist Therapeutics names 19 peer companies for pay. Among Protagonist Therapeutics and these peers, CEO pay was 2nd highest of 5 and total shareholder return was 2nd highest of 5.
2nd highest of 5in Protagonist Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
2nd highest of 5in Protagonist Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Harold E. SelickChair · 16 yr on the boardIndependentCompensation, Nominating and Corporate Governance, Research—Paid as an executive
- Lewis T. Williams, M.D., Ph.D.Director · 8 yr on the boardIndependentCompensation, Research—Paid as an executive
- Bryan GiraudoDirector · 7 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
- Sarah A. O’DowdDirector · 5 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 28, 2026 | FY2025 |
| Annual report | 10-K | Feb 25, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 29, 2025 | FY2024 |
| Annual report | 10-K | Feb 21, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Feb 27, 2024 | FY2023 |
